These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33189452)

  • 21. Coronavirus infection in patients with diabetes.
    Torres-Tamayo M; Caracas-Portillo NA; Peña-Aparicio B; Juárez-Rojas JG; Medina-Urrutia AX; Martínez-Alvarado MDR
    Arch Cardiol Mex; 2020; 90(Supl):67-76. PubMed ID: 32523141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin-converting enzyme 2: A protective factor in regulating disease virulence of SARS-COV-2.
    Mariappan V; S R R; Balakrishna Pillai A
    IUBMB Life; 2020 Dec; 72(12):2533-2545. PubMed ID: 33031602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular Endothelial Glycocalyx Damage in COVID-19.
    Yamaoka-Tojo M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysregulation of Angiotensin Converting Enzyme 2 Expression and Function in Comorbid Disease Conditions Possibly Contributes to Coronavirus Infectious Disease 2019 Complication Severity.
    Hammoud SH; Wehbe Z; Abdelhady S; Kobeissy F; Eid AH; El-Yazbi AF
    Mol Pharmacol; 2021 Jan; 99(1):17-28. PubMed ID: 33082267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ACE2: The Major Cell Entry Receptor for SARS-CoV-2.
    Scialo F; Daniele A; Amato F; Pastore L; Matera MG; Cazzola M; Castaldo G; Bianco A
    Lung; 2020 Dec; 198(6):867-877. PubMed ID: 33170317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronavirus SARS-Cov-2 and arterial hypertension - facts and myths.
    Surma S; Romańczyk M; Łabuzek K
    Pol Merkur Lekarski; 2020 Jun; 48(285):195-198. PubMed ID: 32564046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Periodontal pocket and COVID-19: Could there be a possible link?
    Elisetti N
    Med Hypotheses; 2021 Jan; 146():110355. PubMed ID: 33183854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes and COVID-19; A Bidirectional Interplay.
    Kazakou P; Lambadiari V; Ikonomidis I; Kountouri A; Panagopoulos G; Athanasopoulos S; Korompoki E; Kalomenidis I; Dimopoulos MA; Mitrakou A
    Front Endocrinol (Lausanne); 2022; 13():780663. PubMed ID: 35250853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is It All About Endothelial Dysfunction and Thrombosis Formation? The Secret of COVID-19.
    Elyaspour Z; Zibaeenezhad MJ; Razmkhah M; Razeghian-Jahromi I
    Clin Appl Thromb Hemost; 2021; 27():10760296211042940. PubMed ID: 34693754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial dysfunction in Coronavirus disease 2019 (COVID-19): Gender and age influences.
    Froldi G; Dorigo P
    Med Hypotheses; 2020 Nov; 144():110015. PubMed ID: 32592919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible role of exogenous melatonin in preventing more serious COVID-19 infection in patients with type 2 diabetes mellitus.
    Martorina WJ; Tavares A
    Rev Assoc Med Bras (1992); 2021; 67Suppl 1(Suppl 1):18-21. PubMed ID: 34259775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients.
    Montiel V; Lobysheva I; Gérard L; Vermeersch M; Perez-Morga D; Castelein T; Mesland JB; Hantson P; Collienne C; Gruson D; van Dievoet MA; Persu A; Beauloye C; Dechamps M; Belkhir L; Robert A; Derive M; Laterre PF; Danser AHJ; Wittebole X; Balligand JL
    EBioMedicine; 2022 Mar; 77():103893. PubMed ID: 35219085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 Is an Endothelial Disease: Implications of Nitric Oxide.
    Kidde J; Gorabi AM; Jamialahmadi T; Sahebkar A
    Adv Exp Med Biol; 2021; 1321():109-113. PubMed ID: 33656717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course.
    Landstra CP; de Koning EJP
    Front Endocrinol (Lausanne); 2021; 12():649525. PubMed ID: 34220706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 and diabetes: the contributions of hyperglycemia.
    Wang J; Meng W
    J Mol Cell Biol; 2020 Sep; 12(12):958-962. PubMed ID: 33002109
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of T-cell immunity in COVID-19 severity amongst people living with type II diabetes.
    Tong ZWM; Grant E; Gras S; Wu M; Smith C; Barrett HL; Gallo LA; Short KR
    FEBS J; 2021 Sep; 288(17):5042-5054. PubMed ID: 34216102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 - A vascular disease.
    Siddiqi HK; Libby P; Ridker PM
    Trends Cardiovasc Med; 2021 Jan; 31(1):1-5. PubMed ID: 33068723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between diabetes and COVID-19: A narrative review.
    Sabri S; Bourron O; Phan F; Nguyen LS
    World J Diabetes; 2021 Oct; 12(10):1674-1692. PubMed ID: 34754370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Potential of Dietary Bioactive Compounds against SARS-CoV-2 and COVID-19-Induced Endothelial Dysfunction.
    Losso JN
    Molecules; 2022 Mar; 27(5):. PubMed ID: 35268723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.